Table 1.
Cohort demographics including age, sex, and SF concentration of CCL22
| Cohort | Age | Sex | Synovial fluid CCL22 conc. (ng/mL) | Synovial fluid CCL22 conc. (ng/mL) mean +SD |
|---|---|---|---|---|
| Normal | 45 | Female | 0.15 | 0.17 ± 0.11 |
| Normal | 55 | Female | 0.16 | |
| Normal | 57 | Female | 0.13 | |
| Normal | 62 | Female | 0.41 | |
| Normal | 49 | Male | 0.28 | |
| Normal | 50 | Male | 0.04 | |
| Normal | 52 | Male | 0.09 | |
| Normal | 52 | Male | 0.10 | |
| Normal | 57 | Male | 0.08 | |
| Normal | 65 | Male | 0.23 | |
| OA | 43 | Female | 1.38 | 1.63 ± 1.33 |
| OA | 51 | Female | 2.16 | |
| OA | 52 | Female | 1.18 | |
| OA | 54 | Female | 0.16 | |
| OA | 55 | Female | 2.14 | |
| OA | 55 | Female | 0.23 | |
| OA | 61 | Female | 0.28 | |
| OA | 64 | Female | 0.12 | |
| OA | 50 | Male | 2.47 | |
| OA | 52 | Male | 0.44 | |
| OA | 52 | Male | 3.44 | |
| OA | 58 | Male | 2.82 | |
| OA | 64 | Male | 4.31 |
CCL22 levels were different between normal versus OA cohorts (p = 0.0034). Age was not different between the cohorts (p = 0.9086).